| Literature DB >> 21776204 |
Vinicius J B Martins1, Telma M M Toledo Florêncio, Luciane P Grillo, Maria do Carmo P Franco, Paula A Martins, Ana Paula G Clemente, Carla D L Santos, Maria de Fatima A Vieira, Ana Lydia Sawaya.
Abstract
Undernutrition is one of the most important public health problems, affecting more than 900 million individuals around the World. It is responsible for the highest mortality rate in children and has long-lasting physiologic effects, including an increased susceptibility to fat accumulation mostly in the central region of the body, lower fat oxidation, lower resting and postprandial energy expenditure, insulin resistance in adulthood, hypertension, dyslipidaemia and a reduced capacity for manual work, among other impairments. Marked changes in the function of the autonomic nervous system have been described in undernourished experimental animals. Some of these effects seem to be epigenetic, passing on to the next generation. Undernutrition in children has been linked to poor mental development and school achievement as well as behavioural abnormalities. However, there is still a debate in the literature regarding whether some of these effects are permanent or reversible. Stunted children who had experienced catch-up growth had verbal vocabulary and quantitative test scores that did not differ from children who were not stunted. Children treated before 6 years of age in day-hospitals and who recovered in weight and height have normal body compositions, bone mineral densities and insulin production and sensitivity.Entities:
Keywords: body composition; dyslipidaemia; energy expenditure; hypertension; insulin; undernutrition
Mesh:
Substances:
Year: 2011 PMID: 21776204 PMCID: PMC3137999 DOI: 10.3390/ijerph8061817
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1.Resting metabolic rate (J/day) (mean7s.d.) over the follow-up time (nonstunted ⋄; stunted ▪). ANOVA: group factor (F (1.20) = 3.04; P = NS), time factor (F (3.60) = 12.7; P < 0.001), and interaction factor (F (3.60) = 4.7; P = 0.005). Reprinted with permission from Eur. J. Clin. Nutr. [45].
Figure 2.Rate of weight gain/y (mean7s.d.) over the follow-up time (nonstunted ⋄; stunted ▪). ANOVA: group factor (F (1.24) = 0.01; P = NS), time factor (F (2.48) = 3.99; P = 0.02), and interaction factor (F (2.48) = 3.99; P = 0.002). Reprinted with permission from Eur. J. Clin. Nutr. [45].
Figure 3.Changes in body composition of stunted ( ) and nonstunted children (□) (overall group) between the two study visits. (a) fat mass; (b) lean mass; (c) fat mass percentage; (d) lean mass percentage. The boxes represent the interquartile ranges, which contain 50% of values; the whiskers are the highest and lowest values (excluding outliers), and the line across each box indicates the median. Reprinted with permission from Brit. J. Nutr. [26].
Gains in bone mineral content and bone mineral density, according to nutritional status and sex.
| Arms (g) | 46.44 ± 16.90 | 21.63 ± 9.99 | 48.77 ± 21.31 | 30.74 ± 13.40 |
| Legs (g) | 154.03 ± 45.03 | 35.65 ± 165.06 | 127.17 ± 42.79 | 73.83 ± 18.05 |
| Trunk (g) | 135.34 ± 103.64 | 67.62 ± 22.79 | 169.14 ± 66.95 | 82.43 ± 75.06 |
| Total (g) | 557.86 ± 206.66 | 275.34 ± 107.69 | 570.87 ± 211.26 | 330.85 ± 133.78 |
| Arms (g/cm2) | 0.054 ± 0.047 | 0.027 ± 0.026 | 0.067 ± 0.042 | 0.037 ± 0.042 |
| Legs (g/cm2) | 0.209 ± 0.080 | 0.108 ± 0.057 | 0.184 ± 0.062 | 0.094 ± 0.030 |
| Total (g/cm2) | 0.099 ± 0.059 | 0.038 ± 0.043 | 0.114 ± 0.058 | 0.051 ± 0.048 |
Values expressed are mean ± standard deviation;
Significantly different from the eutrophic group, p < 0.05;
Significantly different from the eutrophic group, p < 0.001.
Figure 4.Correlation between SBP and (A) AngII and (B) ACE activity for girls (open symbols) and boys (solid symbols). The solid lines represent the linear regression and the broken lines are the 95% confidence intervals. Reprinted with permission from Clin. Sci. [67].
Productivity, energy intake and nutrients according to BMI of sugarcane cutters studied at a plantation in Marechal Deodoro (Alagoas, Brazil).
| <21.5 | 25(40.3%) | 7.48 ± 1.5 | 12,380 ± 4,184 | 2.0 ± 0.5 | 7.4 ± 3.6 | 0.8 ± 0.6 |
| 21.5–25 | 30 (48.4%) | 9.12 ± 1.5 | 16,506 ± 6,360 | 2.1 ± 1.5 | 9.8 ± 4.1 | 1.7 ± 0.7 |
| >25 | 7 (11.3%) | 7.80 ± 1.7 | 13,215 ± 1,251 | 2.0 ± 0.5 | 8.5 ± 1.4 | 1.2 ± 0.3 |
ñ < 0.05; reprinted with permission from Arch. Latinoamer. Nutr. [104].
Productivity, intake of energy and proteins, body fat composition and average age of sugarcane cutters at a plantation in Marechal Deodoro (Alagoas, Brazil) distributed according to height groups.
| 158–159.9 | 12 (19.4%) | 42 ± 12.3 | 7.14 ± 1.6 | 14,292 ± 4,300 | 2.2 ± 0.7 | 17.7 ± 4.3 | 16.6 ± 5.7 | 1.1 |
| 160–164.9 | 16 (25.8%) | 35 ± 10.7 | 7.90 ± 1.7 | 11,593 ± 4,449 | 1.8 ± 0.7 | 13.7 ± 2.2 | 12.9 ± 2.0 | 0.8 |
| 165–169.9 | 12 (19.4%) | 37 ± 10.3 | 7.95 ± 1.5 | 12,041 ± 3,969 | 1.9 ± 0.7 | 13.3 ± 3.6 | 12.4 ± 4.3 | 0.9 |
| 170–174.9 | 12 (19.4%) | 30 ± 8.6 | 9.01 ± 1.5 | 15,388 ± 5,217 | 2.4 ± 0.5 | 12.3 ± 3.5 | 11.4 ± 2.5 | 0.9 |
| =175 | 10 (16.1%) | 26 ± 7.4 | 8.65 ± 1.4 | 15,551 ± 6,758 | 2.2 ± 0.7 | 9.8 ± 2.5 | 9.5 ± 1.9 | 0.3 |
p < 0.05; reprinted with permission from Arch. Latinoamer. Nutr. [104].
Figure 5.Association between short stature, obesity, hypertension, diabetes and work capacity.
Characteristics of weight and height gain according to the studied variables among children (n = 106) aged 0 to 72 months living in southern Sao Paulo, Brazil, who attended a daily care service.
| Age at admission (months), median | 17.4 | 17.5 | 20.9 | 24.2 | 0.527 | 10.8 | 21.4 | 23.2 | 19.1 | 0.338 |
| Gender (% male) | 57.1 | 47.7 | 59.1 | 36.8 | 0.464 | 66.7 | 50.0 | 42.9 | 42.9 | 0.343 |
| Duration of treatment (months), mean | 10.1 | 14.8 | 19.7 | 23.0 | <0.001 | 9.2 | 12.9 | 22.2 | 21.7 | 0.957 |
| Fetal development (% premature) | 20.0 | 18.4 | 25.0 | 29.4 | 0.811 | 21.1 | 25.9 | 20.0 | 21.1 | 0.957 |
| Birth weight (kg), mean | 2.593 | 2.648 | 2.550 | 2.317 | 0.103 | 2.670 | 2.619 | 2.604 | 2.295 | 0.045 |
| Small for gestational age (%) | 27.8 | 21.4 | 19.1 | 50.0 | 0.129 | 21.1 | 18.2 | 23.1 | 52.6 | 0.026 |
| WAZ at admission, mean | −2.04 | −2.08 | −2.49 | −2.52 | <0.001 | −2.22 | −2.07 | −2.26 | −2.51 | 0.041 |
| HAZ at admission, mean | −1.92 | −1.91 | −2.36 | −2.26 | 0.061 | −1.63 | −1.78 | −2.27 | −2.71 | <0.001 |
| Frequent URTI (rate 10–3) | 55.3 | 26.2 | 44.1 | 33.4 | 0.011 | 22.9 | 36.8 | 37.3 | 39.3 | 0.226 |
| Frequent LRTI (rate 10–3) | 5.8 | 2.4 | 1.3 | 0.5 | 0.857 | 1.8 | 3.7 | 1.3 | 1.7 | 0.712 |
| Frequent diarrhoea (rate 10–3) | 11.2 | 5.6 | 6.0 | 6.0 | 0.215 | 7.1 | 10.7 | 3.5 | 6.0 | 0.201 |
| Maternal education (years), mean | 2.1 | 2.4 | 2.3 | 2.3 | 0.767 | 2.5 | 2.3 | 2.1 | 2.3 | 0.347 |
| Family income (R$), median | 300 | 300 | 352 | 268 | 0.454 | 350 | 300 | 300 | 300 | 0.721 |
WAZ, weight-for-age Z-score; HAZ, height-for-age Z-score; URTI, upper respiratory tract infection; LRTI, lower respiratory tract infection;
Kruskal–Wallis test;
x2 test;
One-way ANOVA test for linear trend;
x2 test for linear trend; Reprinted with permission from Public Health Nutr. [106].
Insulin, homeostasis model assessment of pancreatic b-cell function (HOMA-B), homeostasis model assessment of insulin sensitivity (HOMA-S) and glucose concentration for boys and girls in the control and recovered groups (Mean values with their standard errors).
| Insulin (pmol/L) | 15 | 3.62 | 0.40 | 28 | 3.76 | 0.28 | NS | 9 | 3.78 | 0.26 | 30 | 3.52 | 0.09 | NS |
| Glucose (mg/dL) | 15 | 78,90 | 5.92 | 27 | 73.28 | 4.23 | NS | 9 | 75.54 | 4.38 | 29 | 79.04 | 1.65 | NS |
| HOMA-B (%) | 15 | 4.71 | 0.308 | 27 | 4.92 | 0.220 | NS | 9 | 4.84 | 0.206 | 29 | 4.59 | 0.076 | NS |
| HOMA-S (%) | 15 | 4.85 | 0.403 | 27 | 4.75 | 0.288 | NS | 10 | 4.73 | 0.264 | 30 | 4.96 | 0.098 | NS |
NS, P > 0.05;
Logarithmically transformed;
From analysis of covariance with means adjusted for age and pubertal stage; Reprinted with permission from Brit. J. Nutr. [108].
Table of Acronyms (in alphabetical order)
| ACE | Angiotensin-Converting Enzyme |
| ACTH | Adrenocorticotropic Hormone |
| AH | Arterial Hypertension |
| AngII | Angiotensin II |
| BMC | Bone Mineral Content |
| BMD | Bone Mineral Density |
| BMI | Body Mass Index |
| BP | Blood Pressure |
| CREN | Center For Nutritional Recovery And Education |
| CRH | Corticotrophin Releasing Hormone |
| DALYs | Disability-Adjusted Life Years |
| DXA | Dual-Energy X-Ray Absorptiometry |
| GH | Growth Hormone |
| HAZ | Height-for-Age |
| HDL | High-Density Lipoprotein |
| HOMA | Homeostasis Model Assessment |
| HPA | Hypothalamic Pituitary Adrenocortical System |
| IGF-1 | Insulin-Like Growth Factor type 1 |
| LBM | Lean Body Mass |
| LBW | Low Birth Weight |
| LDL | Low-Density Lipoprotein |
| LRTI | Lower Respiratory Tract Infection |
| OR | Odds Ratio |
| RDA | Recommended Dietary Allowances |
| RMR | Resting Metabolic Rates |
| RQs | Respiratory Quotient |
| SAM | Sympathetic Adrenomedullary (System) |
| SBP | Systolic Blood Pressure |
| SGA | Small for Gestational Age |
| TEE | Total Energy Expenditure |
| TNF- α | Tumoral Necrosis Factor - Alpha |
| TRH | Thyrotropin Releasing Hormone |
| TSH | Thyroid Stimulating Hormone |
| URTI | Upper Respiratory Tract Infection |
| WAZ | Weight-for-Age |
| WHZ | Weight-for-Height |